联系方式职　　称: 教授、博士生导师
所在部门: 生物物理学研究所
　办公室:
联系电话:
传真号码:
电子邮件: wuy@
个人主页:

学习经历■ 1993.9-1998.7，清华大学材料科学与工程系，获工学学士学位；
■ 1998.9-2003.7，清华大学生物科学与技术系，获理学博士学位。


工作经历■ 2003.9至今，兰州大学生命科学学院，教学科研；
社会工作■ 中国生物物理学会理事，2006-；
■ 中国电子显微镜学会理事，2008-；
■ 生物物理学报副主编，2010-；
■ Biophysics Reports副主编，2015-。


研究方向■重要蛋白质参与慢性炎症疾病调控的分子机制；
■电镜结构生物学解析蛋白质复合体的构象变化。


项目成果■ 国家自然科学基金重点项目1项，面上项目13项；
■ 国家自然科学基金优秀青年科学基金1项；
■ 国家自然科学基金国际合作项目2项；
■ 霍英东青年教师基金1项；
■ 教育部新世纪优秀人才支持计划2项；
■ 教育部博士点基金3项；
■ 教育部科技研究重点项目1项；
■ FEI合作研究基金1项；
■ 中央高校基本科研业务费重点项目1项；
■ 兰州大学人才引进专项2项。


荣誉、获奖■ 清华大学优秀博士学位论文一等奖，2003；
■ 教育部新世纪优秀人才支持计划，2005；
■ 国家自然科学二等奖（3/5），2005；
■ 第四届亚太血栓与止血大会青年研究奖，2006；
■ 第六届甘肃青年科技奖，2007；
■ 第十三届甘肃五四青年奖章标兵，2009；
■ 第一届贝时璋青年生物物理学家奖，2009；
■ 第十二届霍英东青年教师基金，2010；
■ 国家自然科学基金优秀青年基金，2012。

教学及指导研究生情况 研究团队：教授2人、副教授2人，研究生14人。

发表论文及专著 已发表SCI论文32篇，共获SCI引用1100余次；代表性论文（*通讯作者）：
[1]Zhang S.-C., Wang M.-Y., Feng J.-R., Chang Y., Ji S.-R. *, Wu Y.* (2020) Reversible promoter methylation determines fluctuating expression of acute phase proteins. eLife, 9: e51317. (IF 7.551)
[2]Li H.-Y., Liu X.-L., Liu Y.-T., Jia Z.-K., Filep J.G., Potempa L.A., Ji S.-R. *, Wu Y.* (2019) Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein. Cardiovascular Research, 115(2): 440-452. (IF 7.014)
[3]Zhang L., Li H.-Y., Li W., Shen Z.-Y., Wang Y.-D., Ji S.-R. *, Wu Y.* (2018) An ELISA assay for quantifying monomeric C-reactive protein in plasma. Frontiers in Immunology, 9: 511. (IF 5.511)
[4]Jia Z.-K., Li H.-Y., Liang Y.-L., Potempa L.A., Ji S.-R.*,Wu Y.*(2018) Monomeric C-reactive protein binds and neutralizes RANKL-induced osteoclast differentiation.Frontiers in Immunology, 9: 234.(IF5.51)
[5]Lv J.-M., Lv S.-Q., Liu Z.-P., Zhang J., Gao B.-X., Yao Z.-Y., Wu Y.-X., Potempa L.A., Ji S.-R.*,Long M.*,Wu Y.*(2018) Conformational folding and disulfide bonding drive distinct stages of protein structure formation.Scientific Reports,8: 1494.(IF4.122)
[6]Li Q.-Y., Li H.-Y., Fu G., Yu F.*,Wu Y.*, Zhao M.-H. (2017) Autoantibodies against C-reactive protein influences complement activation and clinical course in lupus nephritis.Journal of the American Society of Nephrology,28 (10): 3044-3054.(IF8.655)
[7]Li H.-Y., Wang J., Meng F., Jia Z.-K., Su Y., Bai Q.-F., Lv L.-L., Ma F.-R., Potempa L.A., Ji S.-R.*, Wu Y.* (2016) An intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein. Journal of Biological Chemistry, 291 (16): 8795-8804. (IF 4.01)
[8]Ouyang Y., Zhu L.*, Li Y.-F., Guo M.-M., Liu Y., Cheng J., Zhao J., Wu Y.* (2016) Architectural plasticity of AMPK revealed by electron microscopy and X-ray crystallography. Scientific Reports, 6:24191.(IF 4.122)
[9]Zhang L., Liu S.-H., Wright T.T., Shen Z.-Y., Li H.-Y., Zhu W., Potempa L.A., Ji S.-R.*, Szalai A.J.*, Wu Y.* (2015) C-reactive protein directly suppresses T helper 1 cell differentiation and alleviates experimental autoimmune encephalomyelitis. Journal of Immunology,194 (11): 5243-5252. (IF 4.539)
[10]Li H.-Y., Wang J., Wu Y.-X., Zhang L., Liu Z.-P., Filep J.G., Potempa L.A., Wu Y.*, Ji S.-R.* (2014) Topological localization of monomeric C-reactive protein determines pro-inflammatory endothelial cell responses. Journal of Biological Chemistry, 289 (20): 14283-14290. (IF4.01)
[11]Wang M.-Y., Zhou H.-H., Zhang S.-C., Hui F., Zhu W., Su H.-X., Guo H.-Y., Li X.-W., Ji S.-R.*, Wu Y.* (2014) Recurrent mutations at C-reactive protein promoter SNP position -286 in human cancers. Cell Research, 24(4): 505-508. (IF 15.393)
[12]Zhang Y.-J., Shi J.-M., Bai C.-J., Wang H., Li H.-Y., Wu Y.*, Ji S.-R.* (2012) Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay. Journal of Biological Chemistry, 287(1): 748-756. (IF4.01)
[13]El Kebir D., Zhang Y., Potempa L.A., Wu Y., Fournier A., Filep J.G.* (2011) C-reactive protein-derived peptide 201–206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. Journal of Leukocyte Biology, 90(6): 1167-1175. (IF 4.224)
[14]Wang M.-Y., Ji S.-R., Bai C.-J., El Kebir D., Li H.-Y., Shi J.-M., Zhu W., Costantino S., Zhou H.-H., Potempa L.A., Zhao J., Filep J.G.*, Wu Y.* (2011) A redox switch in C-reactive protein modulates activation of endothelial cells. FASEB Journal, 25(9): 3186-3196. (IF5.595)
[15]Zhu L., Chen L., Zhou X.-M., Zhang Y.-Y., Zhang Y.-J., Zhao J., Ji S.-R., Wu J.-W.*, Wu Y.* (2011) Structural insights into the architecture and allostery of full-length AMP-activated protein kinase. Structure, 19(4): 515-522. (IF 4.907)
[16]Wang B.-B., Yu C.-H., Xi Y.-B., Cai H.-C., Wang J., Zhou S.-R., Zhou S.-Y., Wu Y., Yan Y.-B.*, Ma X.*, Xie L.-X.* (2011) A novel CRYGD mutation (p.Trp43Arg) causing autosomal dominant congenital cataract in a Chinese family. Human Mutation, 32(1): E1939-E1947. (IF 5.359)
[17]Liu R.-Q., Zhou Q.-H., Ji S.-R., Zhou Q., Feng D., Wu Y., Sui S.-F.* (2010) Membrane localization of β-Amyloid 1–42 in lysosomes: a possible mechanism for lysosome labilization. Journal of Biological Chemistry, 285(26): 19986-19996. (IF4.01)
[18]Ji S.-R., Ma L., Bai C.-J., Shi J.-M., Li H.-Y., Filep J.G., Potempa L.A., Zhao J., Wu Y.* (2009) Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft micro-domains. FASEB Journal, 23(6): 1806-1816. (IF5.595)
[19]Shen Q.T., Bai X.C., Chang L.F., Wu Y., Wang H.W., Sui S.-F.* (2009) Bowl-shaped oligomeric structures on membranes as DegP’s new functional forms in protein quality control. Proceedings of the National Academy of Sciences of the United States of America, 106(12): 4858-4863. (IF9.504)
[20]Jiang J., Zhang X., Chen Y., Wu Y., Zhou Z.H., Chang Z., Sui S.-F.* (2008) Activation of DegP chaperone-protease via formation of large cage-like oligomers upon binding to substrate proteins. Proceedings of the National Academy of Sciences of the United States of America, 105(33): 11939-11944. (IF 9.504)
[21]Ji S.-R., Wu Y.*, Zhu L., Potempa L.A., Sheng F.-L., Lu W., Zhao J. (2007) Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm. FASEB Journal, 21(1): 284-294. (IF 5.595)
[22]Ji S.-R., Wu Y.*, Potempa L.A., Liang Y.-H., Zhao J. (2006) Effect of modified C-reactive protein on complement activation: A possible complement regulatory role of mCRP in atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(4): 935-941. (IF 6.086)
[23]Ji S.-R., Wu Y.*, Potempa L.A., Qiu Q., Zhao J. (2006) Interactions of C-reactive protein with low density lipoproteins: implications of an active role of modified C-reactive protein in atherosclerosis. International Journal of Biochemistry & Cell Biology, 384(4): 648-661. (IF 3.247)
[24]Wu Y., He Y., Bai J., Ji S.-R., Tucker W.C., Chapman E.R.*, Sui S.-F.* (2003) Visualization of synaptotagmin I oligomers assembled on lipid monolayers. Proceedings of the National Academy of Sciences of the United States of America, 100(4): 2082-2087. (IF 9.504)
[25]Ji S.-R., Wu Y., Sui S.-F.* (2002) Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (ABeta 1-40), which may potentially inhibit the fibril formation. Journal of Biological Chemistry, 277(8): 6273-6279. (IF4.01)
[26]Wu Y., Wang H.-W., Ji S.-R., Sui S.-F.* (2003) Two-dimensional crystallization of rabbit C-reactive protein monomeric subunits. Acta Crystallographica Section D-Biological Crystallography, 59(5): 922-926. (IF 3.099)

其它信息